DocDollars

Daiichi Sankyo Inc.

NJ · United States · Reporting entity ID 100000000195

Total reported 2019–2025
$270.8M
#49 of 2,960 reporting companies — 0.3% of all reported industry payments
$37.0M in general payments across 297,816 records, plus $233.8M in research funding across 68,526 records.

How it breaks down

General payments $36,975,473
Research funding $233,801,341

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Daiichi Sankyo Inc. reported $270.8M to US doctors and teaching hospitals from 2019 to 2025, ranking #49 of 2,960 reporting companies. 86% of that was research funding and 14% general payments such as consulting, speaking, food and travel. 297,816 general payment records and 68,526 research records were filed.

Common questions about Daiichi Sankyo Inc.

How much has Daiichi Sankyo Inc. paid US doctors?

Daiichi Sankyo Inc. reported $270,776,814 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $36,975,473 in general payments, $233,801,341 in research funding.

How does Daiichi Sankyo Inc. rank among drug and device companies?

It ranks #49 of 2,960 reporting entities by total reported value, about 0.3% of all industry payments in the dataset.

Does a payment from Daiichi Sankyo Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.